Effect of amlodipine on systolic blood pressure

Clinical Therapeutics

Volumn 25, Issue 1, 2003, Pages 35-57

  Levine, Cindy B ^a   Fahrbach, Kyle R ^a   Frame, Diana ^a   Connelly, Janet E ^a   Estok, Rhonda P ^a   Stone, Linda R ^a   Ludensky, Veronica ^a  

^a MetaWorks Inc   (United States)

Author keywords

Amlodipine; Antihypertensive agents; Calcium channel blockers; Systolic hypertension

Indexed keywords

AMLODIPINE BESYLATE; CALCIUM CHANNEL BLOCKING AGENT;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; META ANALYSIS; MONOTHERAPY; PATIENT COMPLIANCE; REVIEW; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

EID: 0037274568     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(03)90007-5     Document Type: Review

References (49)

1. Minino AM, Smith BL. Deaths: Preliminary data for 2000. Natl Vital Stat Rep. 2001;49:1-40.
2. Sheps SG. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Bethesda, Md: National Institutes of Health; 1997. NIH publication 98-4080.
3. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-486.
4. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
5. Shrivastava S, Kochar MS. The need to lower systolic blood pressure. Curr Hypertens Rep. 2000;2:433-440.
6. Psaty BM, Furberg CD, Kuller LH, et al. Association between blood pressure level and the risk of myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study. Arch Intern Med. 2001;161:1183-1192.
7. Benetos A, Thomas F, Bean K, et al. Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med. 2002;162:577-581.
8. Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Arch Intern Med. 1992;152:56-64.
9. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: Blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160:2281-2286.
10. Mancia G, Bombelli M, Lanzarotti A, et al, for the Pressioni Arteriose Monitorate E Loro Associazioni. Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population. Arch Intern Med. 2002;162:582-586.
11. IMS International Prescription Data (total prescriptions based on 35 countries moving annual total), December 2001; IMS National Prescription Audit (total prescriptions), YTD December 2001; IMS Health Services MIDAS Data (cumulative patient-days total), 1990-December 2001.
12. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: Synthesis of best evidence for clinical decisions. Ann Intern Med. 1997;126:376-380.
13. Mulrow CD, Oxman AD, eds. Cochrane Collaboration Handbook. Update Software. Oxford: The Cochrane Library; 1997.
14. Cook DJ, Guyatt GH, Laupacis A, Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1992;102(Suppl 4):305S-311S.
15. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials. 1996;17:1-12.
16. Shadish WR, Haddock CK. Combining estimates of effect size. In: Cooper H, Hedges LV, eds. The Handbook of Research Synthesis. New York: Russell Sage Foundation; 1994:261-281.
17. Hedges LV. Fixed effects models. In: Cooper H, Hedges LV, eds. The Handbook of Research Synthesis. New York: Russell Sage Foundation; 1994:285-299.
18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
19. Calvo C, Gude F, Abellan J, et al. A comparative evaluation of amlodipine and hydrochlorothiazide as monotherapy in the treatment of isolated systolic hypertension in the elderly. Clin Drug Invest. 2000;19:317-326.
20. Fowler G, Webster J, Lyons D, et al. A comparison of amlodipine with enalapril in the treatment of moderate/severe hypertension. Br J Clin Pharmacol. 1993;35:491-498.
21. Webster J, Fowler G, Jeffers TA, et al. A comparison of amlodipine with enalapril in the treatment of isolated systolic hypertension. Br J Clin Pharmacol. 1993;35:499-505.
22. Neaton JD, Grimm RH Jr, Prineas RJ, et al, for the Treatment of Mild Hypertension Research Study Group. Treatment of Mild Hypertension Study Final results. JAMA. 1993;270:713-724.
23. Little P, Barnett J, Barnsley L, et al. Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure. BMJ. 2002;325:254.
24. Fogari R, Zoppi A, Corradi L, et al. Long-term effects of amlodipine versus fosinopril on microalbuminuria in elderly hypertensive patients with type 2 diabetes mellitus. Curr Ther Res Clin Exp. 2000;61:163-173.
25. Tatti P, Pahor M, Byington RP, et al. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care. 1998;21:597-603.
26. Ecder T, Chapman AB, Brosnahan GM, et al. Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2000;35:427-432.
27. Isah AO, Obasohan AO, Oyewo EA, Ohaju-Obodo J. Amlodipine versus nifedipine in the treatment of mild-to-moderate hypertension in black Africans. Curr Ther Res Clin Exp. 1996;57:300-308.
28. Hall WD, Reed JW, Flack JM, et al, for the International Society on Hypertension in Blacks Investigators Group. Comparison of the efficacy of dihydropyridine calcium channel blockers in African American patients with hypertension. Arch Intern Med. 1998;158:2029-2034.
29. Benetos A, Consoli S, Safavian A, et al. Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension. Am Heart J. 2000;140:E11.
30. Emeriau JP, Knauf H, Pujadas JO, et al. A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: A randomized double-blind controlled study. J Hypertens. 2001; 19:343-350.
31. Lacourciere Y, Poirier L, Lefebvre J, et al. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension. Am J Hypertens. 1995;8:1154-1159.
32. Lim PO, Nys M, Naas AA, et al. Irbesartan reduces QT dispersion in hypertensive individuals. Hypertension. 1999;33:713-718.
33. Malacco E, Leonetti G, Santini E et al. Comparison of a calcium antagonist and an ACE inhibitor in the treatment of elderly hypertensive patients. Curr Ther Res Clin Exp. 1993;54:695-702.
34. Pandita-Gunawardena ND, Clarke SE. Amlodipine lowers blood pressure without affecting cerebral blood flow as measured by single photon emission computed tomography in elderly hypertensive subjects. Age Ageing. 1999;28:451-457.
35. Fogari R, Zoppi A, Malamani GD, et al. Effects of amlodipine vs enalapril on microalbuminuria in hypertensive patients with type II diabetes. Clin Drug Invest. 1997;13(Suppl 1):42-49.
36. Fernandez-Andrade C, Russo D, Iversen B, et al. Comparison of losartan and amlodipine in renally impaired hypertensive patients. Kidney Int Suppl. 1998;68:S120-S124.
37. Janssen JJ, Gans RO, van der Meulen J, et al. Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure: A double-blind, randomized prospective study. Am J Hypertens. 1998;11:1074-1079.
38. Kumagai H, Hayashi K, Kumamaru H, Saruta T. Amlodipine is comparable to angiotensin-converting enzyme inhibitor for long-term renoprotection in hypertensive patients with renal dysfunction: A one-year, prospective, randomized study. Am J Hypertens. 2000;13:980-985.
39. Timio M, Verdura C, Lolli S, et al. A comparative study of amlodipine and verapamil in hypertensive patients undergoing haemodialysis. Clin Drug Invest. 1997;13(Suppl 1):73-76.
40. de Bruijn B, Cocco G, Tyler HM. Multicenter placebo-controlled comparison of amlodipine and atenolol in mild to moderate hypertension. J Cardiovasc Pharmacol. 1988;12(Suppl 7):S107-S109.
41. Farsang C, Kawecka-Jaszcz K, Langan J, et al. Antihypertensive effects and tolerability of candesartan cilexetil alone and in combination with amlodipine. Clin Drug Invest. 2001;21:17-23.
42. Frick MH, McGibney D, Tyler HM. A dose-response study of amlodipine in mild to moderate hypertension. J Intern Med. 1989;225:101-105.
43. Frishman WH, Brobyn R, Brown RD, et al. Amlodipine versus atenolol in essential hypertension. Am J Cardiol. 1994;73:50A-54A.
44. Frishman WH, Ram CV, McMahon FG, et al, for the Benazepril/Amlodipine Study Group. Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: A randomized, double-blind, placebo-controlled, parallel-group study. J Clin Pharmacol. 1995;35:1060-1066.
45. Lacourciere Y, Lenis J, Orchard R, et al. A comparison of the efficacies and duration of action of the angiotensin II receptor blockers telmisartan and amlodipine. Blood Press Monit. 1998;3:295-302.
46. Lorimer AR, Smedsrud T, Walker P, Tyler HM, for the Amlodipine Study Group. A comparison of amlodipine, verapamil and placebo in the treatment of mild to moderate hypertension. J Hum Hypertens. 1989;3:191-196.
47. Megnien JL, Levenson J, Del-Pino M, Simon A. Amlodipine induces a flow and pressure-independent vasoactive effect on the brachial artery in hypertension. Br J Clin Pharmacol. 1995;39:641-649.
48. Neutel JM, Rolf CN, Valentine SN, et al. Low-dose combination therapy as first line treatment of mild-to-moderate hypertension: The efficacy and safety of bisoprolol/HCTZ versus amlodipine, enalapril, and placebo. Cardiovasc Rev Rep. 1996;17:33-45.
49. Webster J, Robb OJ, Jeffers TA, et al. Once-daily amlodipine in the treatment of mild to moderate hypertension. J Cardiovasc Pharmacol. 1988;12(Suppl 7):S72-S75.